CU
Columbia University
Columbia University is a seed to Series C stage investment firm. It has made 4 investments. They made 1 investment in the last 12 months. Their most common stage is seed (60% of deals). Average disclosed round size is $37.6M (across 5 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Seed
Last 12 Mo
1
Team
JK
John K. Atsalis
Managing Director
JL
Jonathan Larkin
Managing Director
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series C | $130M | Jan 2026 | |
| AAllied Microbiota | Seed | $1.2M | Oct 2020 |
| RRenBio | Series A | $24M | — |
| RRenBio | Seed | $28M | — |
| AAvoMD, Inc. | Seed | $5M | — |
Top Co-Investors
IndieBio1 shared
500 Emerging Europe1 shared
Mirae Asset1 shared
MedMountain Ventures1 shared
Dunamu1 shared
StartUp Health1 shared
AlleyCorp1 shared
Las Olas Venture Capital1 shared
Alkeon Capital Management1 shared
AVP1 shared
Alumni Ventures1 shared
Twilio Ventures1 shared
Y Combinator1 shared
In-Q-Tel1 shared
Tiger Global Management, LLC1 shared
Wing Venture Capital1 shared
SAP1 shared
Princeville Capital1 shared
Madrona Venture Group1 shared
Last updated: 19 September 2026